T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BREW
2476
DELISTED
Craft Brew Alliance, Inc.
BREW
| $171K | ﹤0.01% |
10,450
+76
| +0.7% | +$1.44K |
|
2477
1-800-Flowers.com
FLWS
$262M
| $170K | ﹤0.01% |
14,382
+161
| +1% | +$2.09K |
|
2478
Protagonist Therapeutics
PTGX
$9.84B
| $170K | ﹤0.01% |
16,500
| – | – |
|
|
HK
2479
DELISTED
Halcon Resources Corporation
HK
| $170K | ﹤0.01% |
37,990
-400
| -1% | -$1.68K |
|
2480
Imunon
IMNN
$6.77M
| $167K | ﹤0.01% |
308
| – | – |
|
2481
NeoGenomics
NEO
$2.11B
| $165K | ﹤0.01% |
10,749
+431
| +4% | +$5.96K |
|
2482
Digi International
DGII
$3.23B
| $160K | ﹤0.01% |
11,923
+100
| +0.8% | +$1.33K |
|
|
QHC
2483
DELISTED
Quorum Health Corporation
QHC
| $159K | ﹤0.01% |
27,100
-37
| -0.1% | -$170 |
|
2484
Rockwell Medical
RMTI
$29.6M
| $158K | ﹤0.01% |
340
-8
| -2% | -$3.88K |
|
|
ARC
2485
DELISTED
ARC Document Solutions, Inc.
ARC
| $157K | ﹤0.01% |
55,163
-50
| -0.1% | -$137 |
|
2486
A10 Networks
ATEN
$2B
| $156K | ﹤0.01% |
25,673
+299
| +1% | +$2.02K |
|
2487
Everspin Technologies
MRAM
$415M
| $156K | ﹤0.01% |
20,300
-8,490
| -29% | -$74.7K |
|
|
MXWL
2488
DELISTED
Maxwell Technologies Inc
MXWL
| $155K | ﹤0.01% |
44,394
-363
| -0.8% | -$1.47K |
|
2489
Anavex Life Sciences
AVXL
$316M
| $153K | ﹤0.01% |
55,928
+271
| +0.5% | +$764 |
|
|
VSI
2490
DELISTED
Vitamin Shoppe Inc.
VSI
| $153K | ﹤0.01% |
15,300
| – | – |
|
|
KEYW
2491
DELISTED
The KEYW Holding Corporation
KEYW
| $153K | ﹤0.01% |
17,662
-16,107
| -48% | -$138K |
|
|
GOV
2492
DELISTED
Government Properties Income Trust
GOV
| $149K | ﹤0.01% |
13,239
+585
| +5% | +$9.08K |
|
2493
Geron
GERN
$1.01B
| $148K | ﹤0.01% |
83,937
-2,169
| -3% | -$9.46K |
|
|
HBP
2494
DELISTED
Huttig Building Products, Inc.
HBP
| $148K | ﹤0.01% |
35,039
-266
| -0.8% | -$1.28K |
|
|
FIT
2495
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $147K | ﹤0.01% |
27,409
+421
| +2% | +$2.52K |
|
|
TLGT
2496
DELISTED
Teligent, Inc
TLGT
| $144K | ﹤0.01% |
3,652
+60
| +2% | +$2.4K |
|
2497
Gogo Inc
GOGO
$383M
| $142K | ﹤0.01% |
27,339
-1,952
| -7% | -$8.65K |
|
2498
MiMedx Group
MDXG
$624M
| $141K | ﹤0.01% |
22,759
+719
| +3% | +$3.25K |
|
2499
Amkor Technology
AMKR
$13.8B
| $138K | ﹤0.01% |
18,740
+1,314
| +8% | +$11.2K |
|
2500
VirnetX Holding Corp
VHC
$65.8M
| $137K | ﹤0.01% |
1,472
-40
| -3% | -$2.72K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.